TOKYO (Reuters) – Fujifilm Holdings Corp said on Thursday it concluded a manufacturing contract agreement with VLP Therapeutics for a COVID-19 vaccine formulation.
Fujifilm will use its manufacturing facilities and infrastructure to handle development of the vaccine for clinical trials, the two companies said in a release.
(Reporting by Rocky Swift; Editing by Tom Hogue)
